165 related articles for article (PubMed ID: 34284695)
1. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine.
Sun Y; Gao ZF; Yan WB; Yao BR; Xin WY; Wang CH; Meng QG; Hou GG
Eur J Med Chem; 2020 Jul; 198():112366. PubMed ID: 32371335
[TBL] [Abstract][Full Text] [Related]
3. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
Yao BR; Sun Y; Chen SL; Suo HD; Zhang YL; Wei H; Wang CH; Zhao F; Cong W; Xin WY; Hou GG
Eur J Med Chem; 2019 Apr; 167():187-199. PubMed ID: 30771605
[TBL] [Abstract][Full Text] [Related]
4. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation.
Su CM; Hou GG; Wang CH; Zhang HQ; Yang C; Liu M; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1287-1297. PubMed ID: 31288582
[TBL] [Abstract][Full Text] [Related]
5. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
6. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation.
Zhou YQ; Sun Y; Luo HL; Gao ZF; Zhang HQ; Meng QG; Bai XY; Hou GG; Hou Y
Eur J Med Chem; 2021 Dec; 225():113796. PubMed ID: 34450496
[TBL] [Abstract][Full Text] [Related]
7. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
Li N; Xin WY; Yao BR; Wang CH; Cong W; Zhao F; Li HJ; Hou Y; Meng QG; Hou GG
Eur J Med Chem; 2018 Mar; 147():21-33. PubMed ID: 29421568
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
Zhang L; Chen Q; Hou G; Zhao W; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):264-271. PubMed ID: 30734613
[TBL] [Abstract][Full Text] [Related]
9. Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2
Sun Y; Zhou YQ; Liu YK; Zhang HQ; Hou GG; Meng QG; Hou Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1631-1640. PubMed ID: 32781863
[TBL] [Abstract][Full Text] [Related]
10. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Diphenylpropanes from Daphne giraldii induced apoptosis in hepatocellular carcinoma cells through nuclear factor kappa-B inhibition.
Yao GD; Sun Q; Song XY; Huang XX; Zhang Y; Song SJ
Bioorg Chem; 2018 Apr; 77():619-624. PubMed ID: 29501029
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Effect of Novel 7-Substituted Coumarin Derivatives through Inhibition of NF-κB Signaling Pathway.
Mu C; Wu M; Li Z
Chem Biodivers; 2019 Mar; 16(3):e1800559. PubMed ID: 30556357
[TBL] [Abstract][Full Text] [Related]
15. Koumine Promotes ROS Production to Suppress Hepatocellular Carcinoma Cell Proliferation Via NF-κB and ERK/p38 MAPK Signaling.
Yuan Z; Liang Z; Yi J; Chen X; Li R; Wu J; Sun Z
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581704
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity.
Li L; Chen M; Jiang FC
Bioorg Med Chem; 2016 Apr; 24(8):1853-65. PubMed ID: 26972922
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
19. Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis.
Liu Z; Ding F; Shen X
Mol Genet Genomics; 2021 May; 296(3):571-579. PubMed ID: 33576897
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, toxicity and antitumor activity of cobalt carbonyl complexes targeting hepatocellular carcinoma.
Li J; Zhang J; Zhang Q; Wang Y; Bai Z; Zhao Q; He D; Wang Z; Zhang J; Chen Y
Bioorg Med Chem; 2019 Oct; 27(20):115071. PubMed ID: 31472989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
